Stock AUGX AUGMEDIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Augmedix, Inc.

Equities

AUGX

US05105P1075

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
0.86 USD +1.18% Intraday chart for Augmedix, Inc. +0.88% -85.30%
Jun. 04 Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024 CI
May. 29 Augmedix Appoints Alex Stinard as Chief Clinical AI Officer CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024
CI
Top Premarket Decliners
MT
Investors Await Key Inflation Data as US Futures Tread Water in Premarket Session
MT
Augmedix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (AUGX) AUGMEDIX Reports Q1 Revenue $13.5M, vs. Street Est of $13.4M
MT
Augmedix, Inc. Provides Revenue Guidance for the Year 2024
CI
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
CI
North American Morning Briefing : Traders Await -2-
DJ
Augmedix, Inc. Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
CI
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
CI
Top Midday Gainers
MT
Augmedix Shares Surge 15% Premarket Tuesday as Revenue Growth Beats Expectations, Gross Margins Expand in Q4
MT
Earnings Flash (AUGX) AUGMEDIX Reports Q4 Revenue $12.7M, vs. Street Est of $12.4M
MT
Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Augmedix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Augmedix Provides Revenue Guidance for the Year 2024
CI
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
CI
Augmedix, Inc. Revises Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Waning Optimism on Rate Hike Pause, Cisco Fall Pushes Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday
MT
Earnings Flash (AUGX) AUGMEDIX Reports Q3 Revenue $11.8M, vs. Street Est of $11.4M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AUGX Stock
  4. News Augmedix, Inc.
  5. Highlights